SlideShare uma empresa Scribd logo
1 de 34
‫خدا‬ ‫بنام‬
Pearson Syndrome
NARP
F. Mahvelati MD.
Child Neurologist
Pearson Syndrome
 Pearson marrow-pancreas
syndrome was first
described in 1979.
 Less than 100 cases have
been reported worldwide.
 Both sexes are affected
Pearson Syndrome
 The majority of cases are sporadic, although more rarely
familial cases do occur, which can be maternally or
autosomally inherited.
 It can result from either deletion or combined
duplication/deletion mutations.
Pearson Syndrome
 The specific mtDNA
deletion includes deletion
of the complete genes for
ATPases 6 and 8,
cytochrome c oxydase III,
and NADH
dehydrogenase 3, 4, 4L
and 5.
Pearson Syndrome
 mtDNA deletions impair
mitochondrial protein
synthesis due to the loss
of tRNA genes.
Pearson Syndrome
 It is characterised by a
sideroblastic anaemia with
vacuolisation of marrow
precursors, accompanied by
neutropenia,
thrombocytopenia,
exocrine pancreatic
dysfunction and abnormal
liver function, but
neurological symptoms.
Pearson Syndrome
 Neonates may be well at birth, but some 40% of
patients present in the first year with persistent
hypoplastic anemia, other cytopenias, low birth
weight, microcephaly, and multiple organ system
involvement (GI, neuromuscular, and
metabolic).
 Hydrops fetalis has also been reported. Anemic
newborns may need transfusion.
Pearson Syndrome
 During infancy and
early childhood,
failure to thrive,
chronic diarrhea, and
progressive
hepatomegaly often
occur.
Pearson Syndrome
 Episodic crises characterized by somnolence,
vomiting, electrolytic abnormalities, lactic
acidosis (elevated lactate:pyruvate ratio), and
hepatic insufficiency. The lactic acidosis may
become persistent with time.
Pearson Syndrome
 persistent or intermittent lactic acidemia, which is caused
by defects in oxidative phosphorylation.
Pearson Syndrome
 Other organs can be
affected, either
simultaneously or during
the course of the disease.
Pearson Syndrome
Hepatic involvement may cause increases in
transaminase, bilirubin, and lipid levels, as well
as in steatosis. Some patients develop hepatic
failure.
Pearson Syndrome
 Renal involvement is common and manifests as
a tubulopathy, such as Fanconi syndrome.
 Endocrinologic disturbances, such as growth
hormone deficiency, hypothyroidism, and
hypoparathyroidism, may develop but are not
usually part of the initial presentation.
Pearson Syndrome
 The endocrine pancreas usually remains
functional; however, a few patients develop
diabetes mellitus and adrenal insufficiency.
 Splenic atrophy
 Impaired cardiac function
Characteristic vacuolization of a hematopoietic
precursor in the bone marrow. (Light microscopy;
Wright-Giemsa stain)
Pearson Syndrome
 It is diagnosed by the presence of a
single large scale rearrangement of
mtDNA, as observed in Southern
blot hybridization analysis of blood
DNA.
 Southern blot or long-range PCR
for the detection of mtDNA
rearrangement is recommended.
Pearson Syndrome
 Death often occurs before the age of three years,
due to metabolic crisis with lactic acidosis,
bacterial sepsis due to neutropenia, or
hepatocellular failure.
Pearson Syndrome
 Patients who survive early infancy typically
undergo phenotypic evolution:
 Hematological manifestations spontaneously
resolve,
 Neurological and myopathic signs either appear
or worsen. Some patients develop typical KSS
with ophthalmoplegia, ataxia, pigmentary
retinitis, cardiac conduction defects and
myopathy.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
NARP is a maternally transmitted multisystem
disorder of young adult life comprising, in various
combinations.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
It is characterized by developmental delay,
seizures, proximal neurogenic muscle weakness,
ataxia, dementia, sensory neuropathy, and
retinitis pigmentosa.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
MILS is a multisystem degenerative
encephalopathy with onset in infancy,
characterized by hypotonia, myoclonus,
brainstem dysfunction, peripheral neuropathy,
developmental delay, psychomotor regression,
ataxia, seizures, and optic atrophy.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
In 90% of NARP cases, It is associated with a
Complex V: T8993G point mutation (mutation
resulting in the replacement of a leucine by arginine)
in the ATPase 6 gene (MTATP6; subunit 6 of
complex V)
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
When the percentage of mutant mtDNA is >95%,
patients show the clinical, neuroradiological and
neuropathological findings of maternally inherited
Leigh’s syndrome (MILS).
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
Brain MRI has revealed the presence of
moderate, diffuse cerebral and cerebellar
atrophy, and, in the most severely affected
patients, symmetric lesions of the basal ganglia.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
Brain MRI has revealed the presence of
moderate, diffuse cerebral and cerebellar
atrophy, and, in the most severely affected
patients, symmetric lesions of the basal ganglia.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
Brain MRI has revealed the presence of
moderate, diffuse cerebral and cerebellar
atrophy, and, in the most severely affected
patients, symmetric lesions of the basal ganglia.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
The diagnosis can be confirmed by the
characteristic pathological findings of symmetric
necrotic foci in the thalamus, basal ganglia,
brainstem, and dentate nuclei.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
The diagnosis can be confirmed by the
characteristic pathological findings of symmetric
necrotic foci in the thalamus, basal ganglia,
brainstem, and dentate nuclei.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
Retinitis pigmentosa, present in about half of
MILS patients, is a distinguishing clinical
feature.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
Muscle fibers are COX positive, but a subset of
fibers may be either negative or deficient for
mitochondrial ATPase.
Neuropathy, ataxia, and retinitis pigmentosa (NARP);
maternally inherited Leigh syndrome (MILS)
RRFs are consistently absent in the muscle
biopsy.
Our Time is up!

Mais conteúdo relacionado

Mais procurados

Noonan syndrome
Noonan syndromeNoonan syndrome
Noonan syndromeArun Raj
 
Kearns Sayre Syndrome
Kearns Sayre SyndromeKearns Sayre Syndrome
Kearns Sayre Syndromesasukekakashi
 
Xeroderma pigmentosum
Xeroderma pigmentosumXeroderma pigmentosum
Xeroderma pigmentosumAlaa Osama
 
Mucopolysaccharidosis
MucopolysaccharidosisMucopolysaccharidosis
Mucopolysaccharidosisdas nelaturi
 
Myelodysplastic Syndromes ppt
Myelodysplastic Syndromes  pptMyelodysplastic Syndromes  ppt
Myelodysplastic Syndromes pptArijit Roy
 
Duchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.Padmesh
Duchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.PadmeshDuchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.Padmesh
Duchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.PadmeshDr Padmesh Vadakepat
 
Lysosomal storage disorders
Lysosomal storage disordersLysosomal storage disorders
Lysosomal storage disordersRahul Arya
 
Metachromatic leukodystrophy (mld)
Metachromatic leukodystrophy (mld)Metachromatic leukodystrophy (mld)
Metachromatic leukodystrophy (mld)DR.
 
Neurocutaneous syndrome
Neurocutaneous syndromeNeurocutaneous syndrome
Neurocutaneous syndromeNeurologyKota
 
Myelodysplastic syndrome
Myelodysplastic syndromeMyelodysplastic syndrome
Myelodysplastic syndromeajayyadav753
 
Sotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, Management
Sotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, ManagementSotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, Management
Sotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, ManagementAdnan Rashid, MD
 
Ehlers danlos syndrome case.pptx
Ehlers danlos syndrome case.pptxEhlers danlos syndrome case.pptx
Ehlers danlos syndrome case.pptxAnkitagupta631265
 

Mais procurados (20)

Noonan syndrome
Noonan syndromeNoonan syndrome
Noonan syndrome
 
Trisomy 13
Trisomy 13Trisomy 13
Trisomy 13
 
Mitochondrial diseases
Mitochondrial diseasesMitochondrial diseases
Mitochondrial diseases
 
Kearns Sayre Syndrome
Kearns Sayre SyndromeKearns Sayre Syndrome
Kearns Sayre Syndrome
 
Trisomy21
Trisomy21Trisomy21
Trisomy21
 
Patau Syndrome
Patau SyndromePatau Syndrome
Patau Syndrome
 
Xeroderma pigmentosum
Xeroderma pigmentosumXeroderma pigmentosum
Xeroderma pigmentosum
 
Mucopolysaccharidosis
MucopolysaccharidosisMucopolysaccharidosis
Mucopolysaccharidosis
 
Myelodysplastic Syndromes ppt
Myelodysplastic Syndromes  pptMyelodysplastic Syndromes  ppt
Myelodysplastic Syndromes ppt
 
Duchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.Padmesh
Duchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.PadmeshDuchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.Padmesh
Duchenne muscular dystrophy -Prenatal Diagnosis & Genetic Counseling- Dr.Padmesh
 
Tay Sachs disease
Tay Sachs diseaseTay Sachs disease
Tay Sachs disease
 
Fragile X Syndrome
Fragile X SyndromeFragile X Syndrome
Fragile X Syndrome
 
Lysosomal storage disorders
Lysosomal storage disordersLysosomal storage disorders
Lysosomal storage disorders
 
Albinism
AlbinismAlbinism
Albinism
 
Metachromatic leukodystrophy (mld)
Metachromatic leukodystrophy (mld)Metachromatic leukodystrophy (mld)
Metachromatic leukodystrophy (mld)
 
Neurocutaneous syndrome
Neurocutaneous syndromeNeurocutaneous syndrome
Neurocutaneous syndrome
 
Myelodysplastic syndrome
Myelodysplastic syndromeMyelodysplastic syndrome
Myelodysplastic syndrome
 
Sotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, Management
Sotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, ManagementSotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, Management
Sotos syndrome, Genetics, Radiology, Craniofacial Abnormalities, Management
 
Ehlers danlos syndrome case.pptx
Ehlers danlos syndrome case.pptxEhlers danlos syndrome case.pptx
Ehlers danlos syndrome case.pptx
 
Treatment of CAH
Treatment of CAHTreatment of CAH
Treatment of CAH
 

Semelhante a 5510 18537-1-pb

Approach to Leukodystrophy
Approach to Leukodystrophy Approach to Leukodystrophy
Approach to Leukodystrophy NeurologyKota
 
PROGRESSIVE MYOCLONIC EPILEPSY
PROGRESSIVE MYOCLONIC EPILEPSYPROGRESSIVE MYOCLONIC EPILEPSY
PROGRESSIVE MYOCLONIC EPILEPSYSrirama Anjaneyulu
 
Non compressive myelopathy
 Non compressive myelopathy Non compressive myelopathy
Non compressive myelopathysankalpgmc8
 
Table of genetic_disorders
Table of genetic_disordersTable of genetic_disorders
Table of genetic_disordersMohamed Afzel
 
Genetics of Mitochondrial disorders
Genetics of Mitochondrial disordersGenetics of Mitochondrial disorders
Genetics of Mitochondrial disordersPramod Krishnan
 
motor neuron disease.pptx
motor neuron disease.pptxmotor neuron disease.pptx
motor neuron disease.pptxasdgja
 
Neuroblastoma urology rotation
Neuroblastoma urology rotation Neuroblastoma urology rotation
Neuroblastoma urology rotation Stav Debi
 
ACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptxACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptxchetanpattar7
 
Iem heart disease 26july 2015
Iem    heart disease  26july 2015Iem    heart disease  26july 2015
Iem heart disease 26july 2015rajasthan govt
 
Chromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.GouravChromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.GouravGourav Thakre
 
Update in inherited and syndromic endocrine neoplasms
Update in inherited and syndromic endocrine neoplasms Update in inherited and syndromic endocrine neoplasms
Update in inherited and syndromic endocrine neoplasms Manoj Madakshira Gopal
 
Down syndrome and Physiotherapy Management
Down syndrome and Physiotherapy Management Down syndrome and Physiotherapy Management
Down syndrome and Physiotherapy Management Anumeha Sharma
 
Haas diagnosis 2012
Haas diagnosis 2012Haas diagnosis 2012
Haas diagnosis 2012mitoaction
 
Wilson’s disese.pptx
Wilson’s disese.pptxWilson’s disese.pptx
Wilson’s disese.pptxMohamadAlhes
 
Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)Caroline Karunya
 

Semelhante a 5510 18537-1-pb (20)

Approach to Leukodystrophy
Approach to Leukodystrophy Approach to Leukodystrophy
Approach to Leukodystrophy
 
PROGRESSIVE MYOCLONIC EPILEPSY
PROGRESSIVE MYOCLONIC EPILEPSYPROGRESSIVE MYOCLONIC EPILEPSY
PROGRESSIVE MYOCLONIC EPILEPSY
 
Non compressive myelopathy
 Non compressive myelopathy Non compressive myelopathy
Non compressive myelopathy
 
Table of genetic_disorders
Table of genetic_disordersTable of genetic_disorders
Table of genetic_disorders
 
Genetics of Mitochondrial disorders
Genetics of Mitochondrial disordersGenetics of Mitochondrial disorders
Genetics of Mitochondrial disorders
 
motor neuron disease.pptx
motor neuron disease.pptxmotor neuron disease.pptx
motor neuron disease.pptx
 
İbrahi̇m bi̇ldi̇ri̇ci̇
İbrahi̇m bi̇ldi̇ri̇ci̇İbrahi̇m bi̇ldi̇ri̇ci̇
İbrahi̇m bi̇ldi̇ri̇ci̇
 
Syndromes
SyndromesSyndromes
Syndromes
 
Neuroblastoma urology rotation
Neuroblastoma urology rotation Neuroblastoma urology rotation
Neuroblastoma urology rotation
 
Genetics of stroke
Genetics of strokeGenetics of stroke
Genetics of stroke
 
GENETIC DISORDERS
GENETIC DISORDERSGENETIC DISORDERS
GENETIC DISORDERS
 
ACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptxACUTE MYELOID LEUKAEMIA.pptx
ACUTE MYELOID LEUKAEMIA.pptx
 
Iem heart disease 26july 2015
Iem    heart disease  26july 2015Iem    heart disease  26july 2015
Iem heart disease 26july 2015
 
Chromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.GouravChromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.Gourav
 
Update in inherited and syndromic endocrine neoplasms
Update in inherited and syndromic endocrine neoplasms Update in inherited and syndromic endocrine neoplasms
Update in inherited and syndromic endocrine neoplasms
 
Down syndrome and Physiotherapy Management
Down syndrome and Physiotherapy Management Down syndrome and Physiotherapy Management
Down syndrome and Physiotherapy Management
 
Haas diagnosis 2012
Haas diagnosis 2012Haas diagnosis 2012
Haas diagnosis 2012
 
Wilson’s disese.pptx
Wilson’s disese.pptxWilson’s disese.pptx
Wilson’s disese.pptx
 
Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)Mitochondrial encephalomyopathies(Neurology)
Mitochondrial encephalomyopathies(Neurology)
 
Genetic disorders
Genetic disordersGenetic disorders
Genetic disorders
 

Mais de Dr Ramesh Krishnan (20)

Diagnosis and management of Hyperkalemia
 Diagnosis and management of Hyperkalemia Diagnosis and management of Hyperkalemia
Diagnosis and management of Hyperkalemia
 
Abg ramesh
Abg rameshAbg ramesh
Abg ramesh
 
Ischemic heart disease
Ischemic heart disease Ischemic heart disease
Ischemic heart disease
 
Approach to management of Hyperkalemia
Approach to management of  HyperkalemiaApproach to management of  Hyperkalemia
Approach to management of Hyperkalemia
 
Anemia in ckd
Anemia in ckd Anemia in ckd
Anemia in ckd
 
Uti
UtiUti
Uti
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Betaadrenergicblockers 150412052808-conversion-gate01
Betaadrenergicblockers 150412052808-conversion-gate01Betaadrenergicblockers 150412052808-conversion-gate01
Betaadrenergicblockers 150412052808-conversion-gate01
 
Alphablockers 140105052831-phpapp02
Alphablockers 140105052831-phpapp02Alphablockers 140105052831-phpapp02
Alphablockers 140105052831-phpapp02
 
Anticholinergics drugs-Dr Ramesh Krishnan
Anticholinergics drugs-Dr Ramesh KrishnanAnticholinergics drugs-Dr Ramesh Krishnan
Anticholinergics drugs-Dr Ramesh Krishnan
 
6966901
69669016966901
6966901
 
Cholinergic ramesh
Cholinergic rameshCholinergic ramesh
Cholinergic ramesh
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Pophyria
PophyriaPophyria
Pophyria
 
Porphyria r
Porphyria rPorphyria r
Porphyria r
 
Porphyria
PorphyriaPorphyria
Porphyria
 
Porphyria r (1)
Porphyria r (1)Porphyria r (1)
Porphyria r (1)
 
Shelly hyperlipidemia
Shelly hyperlipidemiaShelly hyperlipidemia
Shelly hyperlipidemia
 
Cvs 6
Cvs 6Cvs 6
Cvs 6
 
Fri t13 carl_fratter_3.15
Fri t13 carl_fratter_3.15Fri t13 carl_fratter_3.15
Fri t13 carl_fratter_3.15
 

5510 18537-1-pb

  • 1.
  • 3. Pearson Syndrome NARP F. Mahvelati MD. Child Neurologist
  • 4. Pearson Syndrome  Pearson marrow-pancreas syndrome was first described in 1979.  Less than 100 cases have been reported worldwide.  Both sexes are affected
  • 5. Pearson Syndrome  The majority of cases are sporadic, although more rarely familial cases do occur, which can be maternally or autosomally inherited.  It can result from either deletion or combined duplication/deletion mutations.
  • 6. Pearson Syndrome  The specific mtDNA deletion includes deletion of the complete genes for ATPases 6 and 8, cytochrome c oxydase III, and NADH dehydrogenase 3, 4, 4L and 5.
  • 7. Pearson Syndrome  mtDNA deletions impair mitochondrial protein synthesis due to the loss of tRNA genes.
  • 8. Pearson Syndrome  It is characterised by a sideroblastic anaemia with vacuolisation of marrow precursors, accompanied by neutropenia, thrombocytopenia, exocrine pancreatic dysfunction and abnormal liver function, but neurological symptoms.
  • 9. Pearson Syndrome  Neonates may be well at birth, but some 40% of patients present in the first year with persistent hypoplastic anemia, other cytopenias, low birth weight, microcephaly, and multiple organ system involvement (GI, neuromuscular, and metabolic).  Hydrops fetalis has also been reported. Anemic newborns may need transfusion.
  • 10. Pearson Syndrome  During infancy and early childhood, failure to thrive, chronic diarrhea, and progressive hepatomegaly often occur.
  • 11. Pearson Syndrome  Episodic crises characterized by somnolence, vomiting, electrolytic abnormalities, lactic acidosis (elevated lactate:pyruvate ratio), and hepatic insufficiency. The lactic acidosis may become persistent with time.
  • 12. Pearson Syndrome  persistent or intermittent lactic acidemia, which is caused by defects in oxidative phosphorylation.
  • 13. Pearson Syndrome  Other organs can be affected, either simultaneously or during the course of the disease.
  • 14. Pearson Syndrome Hepatic involvement may cause increases in transaminase, bilirubin, and lipid levels, as well as in steatosis. Some patients develop hepatic failure.
  • 15. Pearson Syndrome  Renal involvement is common and manifests as a tubulopathy, such as Fanconi syndrome.  Endocrinologic disturbances, such as growth hormone deficiency, hypothyroidism, and hypoparathyroidism, may develop but are not usually part of the initial presentation.
  • 16. Pearson Syndrome  The endocrine pancreas usually remains functional; however, a few patients develop diabetes mellitus and adrenal insufficiency.  Splenic atrophy  Impaired cardiac function
  • 17. Characteristic vacuolization of a hematopoietic precursor in the bone marrow. (Light microscopy; Wright-Giemsa stain)
  • 18. Pearson Syndrome  It is diagnosed by the presence of a single large scale rearrangement of mtDNA, as observed in Southern blot hybridization analysis of blood DNA.  Southern blot or long-range PCR for the detection of mtDNA rearrangement is recommended.
  • 19. Pearson Syndrome  Death often occurs before the age of three years, due to metabolic crisis with lactic acidosis, bacterial sepsis due to neutropenia, or hepatocellular failure.
  • 20. Pearson Syndrome  Patients who survive early infancy typically undergo phenotypic evolution:  Hematological manifestations spontaneously resolve,  Neurological and myopathic signs either appear or worsen. Some patients develop typical KSS with ophthalmoplegia, ataxia, pigmentary retinitis, cardiac conduction defects and myopathy.
  • 21. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) NARP is a maternally transmitted multisystem disorder of young adult life comprising, in various combinations.
  • 22. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) It is characterized by developmental delay, seizures, proximal neurogenic muscle weakness, ataxia, dementia, sensory neuropathy, and retinitis pigmentosa.
  • 23. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) MILS is a multisystem degenerative encephalopathy with onset in infancy, characterized by hypotonia, myoclonus, brainstem dysfunction, peripheral neuropathy, developmental delay, psychomotor regression, ataxia, seizures, and optic atrophy.
  • 24. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) In 90% of NARP cases, It is associated with a Complex V: T8993G point mutation (mutation resulting in the replacement of a leucine by arginine) in the ATPase 6 gene (MTATP6; subunit 6 of complex V)
  • 25. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) When the percentage of mutant mtDNA is >95%, patients show the clinical, neuroradiological and neuropathological findings of maternally inherited Leigh’s syndrome (MILS).
  • 26. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) Brain MRI has revealed the presence of moderate, diffuse cerebral and cerebellar atrophy, and, in the most severely affected patients, symmetric lesions of the basal ganglia.
  • 27. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) Brain MRI has revealed the presence of moderate, diffuse cerebral and cerebellar atrophy, and, in the most severely affected patients, symmetric lesions of the basal ganglia.
  • 28. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) Brain MRI has revealed the presence of moderate, diffuse cerebral and cerebellar atrophy, and, in the most severely affected patients, symmetric lesions of the basal ganglia.
  • 29. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) The diagnosis can be confirmed by the characteristic pathological findings of symmetric necrotic foci in the thalamus, basal ganglia, brainstem, and dentate nuclei.
  • 30. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) The diagnosis can be confirmed by the characteristic pathological findings of symmetric necrotic foci in the thalamus, basal ganglia, brainstem, and dentate nuclei.
  • 31. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) Retinitis pigmentosa, present in about half of MILS patients, is a distinguishing clinical feature.
  • 32. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) Muscle fibers are COX positive, but a subset of fibers may be either negative or deficient for mitochondrial ATPase.
  • 33. Neuropathy, ataxia, and retinitis pigmentosa (NARP); maternally inherited Leigh syndrome (MILS) RRFs are consistently absent in the muscle biopsy.
  • 34. Our Time is up!